Interleukin-6-174G/C Polymorphism Contributes to Periodontitis Susceptibility: An Updated Meta-Analysis of 21 Case-Control Studies

Zhu, Junfei; Guo, Bin; Fu, Min; Guo, Wushuang; Yuan, Yifang; Yuan, He; Zhang, Suhan; Yu, Haiyang

doi:https://doi.org/10.1155/2016/9612421

Disease Markers

On this page

Abstract Introduction Materials and Methods Results Discussion Authors’ Contributions References Copyright Related Articles

Review Article | Open Access

Volume 2016 | Article ID 9612421 | https://doi.org/10.1155/2016/9612421

Interleukin-6-174G/C Polymorphism Contributes to Periodontitis Susceptibility: An Updated Meta-Analysis of 21 Case-Control Studies

Junfei Zhu,¹Bin Guo,²Min Fu,¹Wushuang Guo,¹Yifang Yuan,¹He Yuan,¹Suhan Zhang,³and Haiyang Yu⁴

Academic Editor: Taina K. Lajunen

Received21 Aug 2016

Accepted18 Oct 2016

Published06 Dec 2016

Abstract

Introduction. Chronic Periodontitis (CP) is suggested to be related to gene variations. Present study aims to quantitatively estimate the association between interleukin-6- (IL-6-) 174G/C polymorphism and CP susceptibility. Materials and Methods. Pubmed, Embase, and Web of Science were searched up to May 2016. The meta-analyses were performed using STATA 12.0. Results. 21 studies were yielded. Significant associations were found under heterozygote comparison and dominant model in studies fulfilling HWE (GC versus GG: OR = 0.690, 95% CI = 0.560–0.849, ; CC + GC versus GG: OR = 0.690, 95% CI = 0.568–0.838, ); significant associations were found under heterozygote comparison and dominant model in Caucasian studies fulfilling HWE (GC versus GG: OR = 0.752, 95% CI = 0.577–0.980, ; CC + GC versus GG: OR = 0.737, 95% CI = 0.576–0.944, ); significant associations were found under allele comparison, heterozygote comparison, and dominant model in Brazilian population (C versus G: OR = 0.648, 95% CI = 0.497–0.845, ; GC versus GG: OR = 0.621, 95% CI = 0.441–0.876, ; CC + GC versus GG: OR = 0.649, 95% CI = 0.470–0.896, ). Conclusion. IL-6 174 polymorphism is associated with CP susceptibility. In Brazilian and Caucasian population, IL-6 174 GG genotype plays as a risk factor to CP.

1. Introduction

Chronic Periodontitis (CP) is a chronic pathological condition characterized by the inflammatory gingiva and the destruction of tooth-supporting structures [1]. The development of CP is facilitated by the interaction of multifactorial bacterial infection and host immune response [2]. The genetic factors, especially those involved in the evolvement of body immune system, have been playing instrumental roles in the pathogenesis of CP [3]. So far, experimental evidences have suggested particular associations between CP and human genetic polymorphisms [4–6]. In this light, CP can be treated as a genotype-related disease and the individual phenotype is determined by the effect of genetic and environmental factors corporately [7].

IL-6 is a pleiotropic cytokine not only exerting immunological effect but also functioning in haematopoiesis, bone metabolism, and tissue regeneration [8, 9]. The associations between IL-6 and CP have been extensively studied because of the role IL-6 played in periodontal host immune reaction and alveolar bone metabolism [10]. The location of human IL-6 gene is reported in the short arm of chromosome 7 (7p21), consisting of 5 exons and 4 introns [11]. There are several polymorphisms in the promoter region of IL-6 like -174 G/C, -572 G/C, -597 G/A, and so forth [12]. Among them, -174 G/C of IL-6, which is also designated as rs1800795, has been confirmed to influence the transitional activity of IL-6 [13].

Although observational studies have been performed to investigate the association between IL-6 -174 G/C polymorphism and CP, the findings were inconsistent [5, 10, 11, 14–19]. Previous meta-analysis demonstrated by Song et al. proposed a link between IL-6 -174 G/C polymorphism and periodontitis susceptibility in Brazilian population [20]. Nevertheless, this meta-analysis assessed CP and aggressive periodontitis (AP) together, and only 11 studies for CP were involved. In recent years, multiple studies were published regarding the association between IL-6 -174 G/C polymorphism and CP [5, 15, 17, 21–26]. Therefore, in present meta-analysis, 21 studies were included to further discover the role of IL-6 -174 G/C polymorphism in the pathogenesis of CP. The object of the present study is to evaluate current studies with more diversified and accurate approaches to assess the relationships between CP susceptibility and IL-6 gene variations.

2. Materials and Methods

Present meta-analysis was performed in accordance with the PRISMA-P (preferred reporting items of systematic reviews and meta-analyses protocols) statement which was recommended for the establishment of a systematic review and meta-analysis [27].

2.1. Eligibility Criteria

The eligibility criteria were as follows: (1) case-control studies; (2) the case groups consisted of patients diagnosed with CP, and the control groups consisted of periodontally healthy individuals; (3) IL-6 -174G/C polymorphism were detected and sufficient data of genotype distribution were provided for the calculation of odds ratio (ORs) and corresponding 95% confidence intervals (CIs); (4) studies with no repeated data. Studies which could not reach the eligibility criteria were excluded.

2.2. Search Strategy

A systemic manuscripts search was performed from the electronic databases including Pubmed, Embase, and Web of Science up to May 2016. In addition, the reference lists of the selected manuscripts and related reviews were also manually searched and screened for a comprehensive search result. The search strategies were presented as follows.

Search Strategies

Pubpmed ((((Periodontal Diseases[Mesh] OR Periodontitis[Mesh]) OR Periodontics[Mesh]) OR (((periodontal disease[Title/Abstract] OR periodontitis[Title/Abstract]) OR periodontal pocket[Title/Abstract]) OR periodontal tissue[Title/Abstract])) AND (((((Interleukin-6[Mesh] OR Interleukin-6[Title/Abstract]) OR Title/Abstract[All Fields]) OR IL-6[Title/Abstract]) OR IL 6[Title/Abstract]) OR Interleukin 6[Title/Abstract])) AND (((((Polymorphism, Genetic[Mesh] OR Genetic Variation[Mesh]) OR Polymorphism[Title/Abstract]) OR Polymorphisms[Title/Abstract]) OR Genetic Variation[Title/Abstract]) OR rs1800795[Title/Abstract])

Embase periodontal disease/exp OR periodontitis/exp OR periodontics/exp OR periodontal disease:ab,ti OR periodontitis:ab,ti OR periodontal pocket:ab,ti OR periodontal tissue:ab,ti AND (Interleukin 6/exp OR Interleukin 6:ab,ti OR IL 6:ab,ti OR rs1800795:ab,ti) AND (DNA polymorphism/exp OR genetic variability/exp OR polymorphism:ab,ti OR polymorphisms:ab,ti OR Genetic Variation:ab,ti)

Web of Science # 1 TS = (periodontal disease) OR TS = (periodontitis) OR TS = (periodontal pocket) OR TS = (periodontal tissue) # 2 TS = (interleukin-6) OR TS = (IL-6) OR TS = (interleukin 6) OR TS = (IL 6) # 3 TS = (polymorphism) OR TS = (polymorphisms) OR TS = (genetic variation) #1 AND #2 AND #3

2.3. Study Selection and Data Extraction

For the study selection, titles and abstracts of the search results were screened firstly and the full-text paper screen was performed next according to eligibility criteria. The results were screened by two authors (JF Zhu and M Fu) independently and a third author (WS Guo) was consulted if any discrepancies existed. The following characteristics were extracted from the eligible studies by two authors (JF Zhu and M Fu) independently, and discrepancies were resolved through discussion as follows: (1) name of the first author and year of publication; (2) country and ethnicity; (3) group size; (4) smoking status; (5) gender ratio comparability; (6) methods of genotyping; (7) type of the controls; (8) genotype distribution; (9) Hardy-Weinberg equilibrium (HWE) for the controls.

2.4. Quality Assessment

The methodological quality of the included studies was evaluated by two authors (JF Zhu and M Fu) independently. Newcastle-Ottawa scale (NOS) was applied for the quality assessment of the included case-control studies. The composition of NOS includes 3 chapters which are “Selection” (0–4 points), “Comparability” (0–2 points), and “Exposure” (0–3 points). For the chapter “Comparability,” ethnicity and gender were selected as the factors to be matched in present study. The final scores were calculated ranging from 0 to 9 [39]. Studies with scores of 0–3, 4–6, and 7–9 points were considered of low, moderate, and high quality, respectively [40].

2.5. Data Analyses

ORs and CIs were calculated to evaluate the association between IL-6 polymorphism and CP. Heterogeneity was estimated by and , > 50% and was considered as significant heterogeneity then the random-effects model was used; otherwise, a fixed-effects model was used to assure the statistical efficiency [41]. The following four genetic models were applied for the meta-analyses of the IL-6 174 G/C polymorphism: (1) allele comparison (C versus G); (2) heterozygote comparison (GC versus GG); (3) the dominant model (CC + GC versus GG); (4) the recessive model (CC versus GC + GG). In addition, the method was used to assess the HWE for the control groups. Subgroup analyses were conducted according to HWE fulfillment, ethnicity, smoking status, gender ratio, and source of the control. Moreover, the following characteristics were included as covariates in the meta-regression to explore the potential sources of heterogeneity: HWE fulfillment, smoking status, gender ratio, source of the controls, and genotyping method, a characteristic was considered as the source of heterogeneity if . Publication bias was measured by Begg’s and Egger’ linear regression test. A significant publication bias was considered if . All of the statistical analyses were processed using the software STATA 12.0.

3. Results

3.1. Study Selection

A total of 373 studies were yielded using the mentioned search strategies. After deleting the duplicates, record screen was performed. And 21 studies [5, 14–18, 21, 22, 24–26, 28–36, 38] involving 2422 CP patients and 3373 healthy individuals were identified to be eligible in present meta-analysis. The process of study selection and the reasons for exclusion are listed in Figure 1.

3.2. Characteristics and Quality Assessment

Of the 21 included studies, 10 studies were conducted in Caucasian population [5, 14, 17, 22, 28–30, 34–36], 6 studies were conducted in Brazilian population [15, 16, 21, 24, 26, 33], 4 studies were conducted in Asian population [18, 25, 32, 38], and 1 study was conducted in Indian population [31]. Seven studies involved nonsmokers as study subjects [5, 15, 22, 24–26, 31]. 12 studies involved case groups and control groups with matched gender ratio [14, 21, 24, 28–36]. Nine studies employed community controls [5, 14, 16, 18, 21, 24, 29, 32, 35, 38]. The control groups of 14 studies fulfilled the HWE [5, 14–16, 18, 21, 22, 24, 26, 29, 31, 33, 36, 38]. The scores of NOS ranged from 5 to 8. 12 studies were considered to be of high quality [5, 14, 16, 18, 21, 28, 29, 31, 32, 35, 36, 38] and 9 studies were considered to be of moderate quality [15, 17, 22, 24–26, 30, 33, 34]. The characteristics and NOS scores of the included studies were listed in Table 1.

3.3. Overall and Subgroup Analysis

For the overall analyses, no significant association was detected between IL-6 174 G/C polymorphism and CP under all of the 4 genetic models but significant heterogeneity was found under each genetic model. When stratified by HWE, significant results were found under heterozygote comparison and dominant model in studies fulfilling HWE (GC versus GG: OR = 0.690, 95% CI = 0.560–0.849, ; = 27.3% ; CC + GC versus GG: OR = 0.690, 95% CI = 0.568–0.838, ; = 44.3% ) (Figure 2). In the stratified analyses by race, no significant association was detected between IL-6 174 G/C polymorphism and CP in Caucasian population (C versus G: OR = 0.957, 95% CI = 0.670–1.366, ; = 80.0% ; CC versus GC + GG: OR = 1.127, 95% CI = 0.495–2.565, ; = 89.0% ; CC + GC versus GG: OR = 0.974, 95% CI = 0.640–1.482, ; % ; CC versus GG: OR = 0.806, 95% CI = 0.453–1.436, ; = 67.2% ); significant associations were found under allele comparison, heterozygote comparison, and dominant model in Brazilian population (C versus G: OR = 0.648, 95% CI = 0.497–0.845, ; = 49.0% ; GC versus GG: OR = 0.621, 95% CI = 0.441–0.876, ; = 6.1% ; CC + GC versus GG: OR = 0.649, 95% CI = 0.470–0.896, ; = 27.8% ) (Figure 3); significant association was found in Asian population under dominant model (CC + GC versus GG; OR = 2.692, 95% CI = 2.160–3.354, ; = 0.0% ); significant associations were found under heterozygote comparison and dominant model in Caucasian studies fulfilling HWE (GC versus GG: OR = 0.752, 95% CI = 0.577–0.980, ; = 55.7% ; CC + GC versus GG: OR = 0.737, 95% CI = 0.576–0.944, ; = 60.8% ) (Figure 4). The results of overall and subgroup analyses were summarized in Table 2.

(a)

(b)

(a)

(b)

(c)

(a)

(b)

3.4. Metaregression

Metaregression showed that the HWE fulfillment was considered as the source of heterogeneity under heterozygote comparison and dominant model (GC versus GG: ; CC + GC versus GG: ). The results of metaregression were summarized in Table 3.

3.5. Publication Bias

No significant publication bias was detected under allele comparison and recessive model. However, the Begg test and Egger linear regression test demonstrated the presence of publication bias with statistical significance under the heterozygote comparison and dominant model (GC versus GG: ; CC + GC versus GG: ).

4. Discussion

IL6 is known to exert an important effect in the pathogenesis of periodontitis [42]. During the development of CP, multiple biological actions could be mediated by the binding of IL-6 and its receptor (IL-6R), including hematopoiesis, angiogenesis induction, immunocyte activation, and osteoclast differentiation [43]. Evidence for the presence of IL-6 in serum, gingival crevicular fluid (GCF), and salivary suggested an altered production of IL-6 in patients with CP [44, 45]. A prolonged excessively-released IL-6 was reported to translate into persistence of oral inflammation and tissue destruction via proteases, osteoclasts, and methylation changes [46–48]. As a chronic inflammatory process caused by bacterial-induced host immune response, CP was proposed to involve genetic factors as determinants [3]. Holla et al. firstly suggested a relationship between IL-6 polymorphism and CP at position 572 [29]. Nibali et al. proposed a positive association between IL-6 174 GG genotype and the presence of A. actinomycetemcomitans and Capnocytophaga sputigena in subgingival plaque [49]. The studies performed by Raunio et al. and D’Aiuto et al. both demonstrated the links between IL-6 174 polymorphism and the presence of IL-6 in patients with severe periodontitis [4, 50]. In addition, the effect of IL-6 174 G/C polymorphism on the susceptibility of CP has been studied by multiple researchers, but the results of these disquisitions were inconclusive [5, 14, 15, 17, 18, 21, 28, 29].

To the extent of our knowledge, present meta-analysis of 21 studies quantitatively explored the association between IL-6 174 G/C polymorphism and CP. Our results provided evidence that IL-6 174 G/C polymorphism is associated with the susceptibility of CP.

As meta-regression suggested, the HWE fulfillment might be the effect modifiers for heterogeneity under heterozygote comparison and dominant model. In the overall analysis and Caucasian subgroup, stratified analyses for HWE lowered the heterogeneity and derived significant results under heterozygote comparison and dominant model, indicating IL-6 174 GG genotype might serve as a risk factor for CP. Beyond that, meta-regression analyses based on smoking status, gender ratio, source of control, and genotyping method have not explored any source of heterogeneity. Further studies based on the difference between population characterizes, such as family history, age, and other living habits, are encouraged to be developed [51].

As revealed by a large body of studies, the associations between genetic polymorphisms and certain diseases varied in different geographical regions and ethnic groups [52–56]. Herein, subgroup analyses based on the ethnicity were performed and the results of the Brazilian subgroup demonstrated insignificant heterogeneity under all of the 5 genetic models. The allele comparison of the Brazilian subgroup suggested that Brazilian CP patients are considered carrying less allele C compared with those periodontally healthy individuals. In addition, the analyses under heterozygote comparison and dominant model presented significant results, which suggested that the GG genotype also plays as a risk factor to CP in Brazilian population.

With regard to the Asian subgroup, present meta-analyses showed a significant result under the dominant model. However, for other genetic models, 2 of the 4 Chinese studies did not report genotype CC in their subject population [18, 38], so that only 2 studies were included in the homozygote comparison and the recessive model. In addition, significant heterogeneities were observed under other 3 genetic models. Pertinent disquisitions on the presence of IL-6 174 CC in Asian population remained conflicting. As suggested by a large body of studies regarding IL-6 174 G/C polymorphism, no genotype CC was found in Asian population [53, 57–61]. However, there are a number of studies indicating that IL-6 174 CC genotype can be detected in Asian individuals [62, 63]. Based on the inconsistency of the IL-6 174 CC distribution of the included Asian studies in present study, a definitive conclusion cannot be drawn in Asian population. Further studies are needed to elucidate the presence of IL-6 174 CC genotype in Asian population.

Shao et al. firstly performed the systematic review and meta-analysis based on the association between IL-6 174 G/C polymorphism and periodontitis in 2009 and demonstrated that GG genotype increased the risk of periodontitis, which was consistent with present findings [64]. In 2013, Song et al. updated this systematic review with lager sample size and stratified analyses based on ethnicity [20]. Compared with previous systematic review conducted by Song et al., present study included 10 more studies and focused on the association between IL-6 174 G/C polymorphism and CP; therefore the study conducted by Nibali et al. was excluded because it investigated CP and AP together [61]. The study performed by Franch-Chillida et al. was excluded for lacking of a classification for the type of periodontitis [65] In addition, NOS was employed for the quality assessment and meta-regression was applied to explore the source of heterogeneity. Moreover, although both present and previous studies reported the associations between IL-6 174 G/C polymorphism and CP in Brazilian population, the results were inconsistent. In the study conducted by Song et al. which included only 2 Brazilian studies, significant associations were found under the models “GG + GC versus CC” and “GG versus CC”, suggesting genotype CC lowers the risk to CP in Brazilian population. Yet present analysis tripled the amount of included Brazilian studies () and demonstrated significant associations under model “C versus G,” “GC versus GG,” and “CC + GC versus GG,” which indicated that allele C play as a protection factor to CP, and genotype GG contributes to the susceptibility of CP. Those 2 findings were inequable but not paradoxical. With the accumulation of further evidences, we believe the association between IL-6 174 G/C polymorphism and CP susceptibility could be clearly elucidated.

The present study however has some limitations. First, although 21 studies were included, the quantity of the included studies was considered insufficient especially for the Asian and Indian subgroups. Additionally, several relevant studies could not be included in present meta-analysis owing to lacking of raw data [23, 66–69] or improper publication formats (Abstract) [6, 37, 70–74]. These might have reduced the number of the included studies and weakened the strength of the present results. Further, although subgroup analyses based on ethnicity were performed, the diversity in geography not only derived different ethnicity but also presented different living habits which exerted effect on CP. Therefore such confounding factors should be noticed when interpreting the results [13]. Moreover, evident publication bias was observed under the heterozygote comparison and dominant model, which might have distorted our present results because of the presence of the gray (unpublished) manuscripts.

In conclusion, within the limitations of this study, the present systematic review and meta-analysis supports that IL-6 174 polymorphism is associated with CP susceptibility. In Brazilian and Caucasian population, IL-6 174 GG genotype plays as a risk factor to CP. Further large-scale studies were required to validate our findings.

Competing Interests

The authors declare that there are no competing interests regarding the publication of this paper.

Authors’ Contributions

Junfei Zhu is the author responsible for manuscript preparation.

References

B. W. Chaffee and S. J. Weston, “Association between chronic periodontal disease and obesity: a systematic review and meta-analysis,” Journal of Periodontology, vol. 81, no. 12, pp. 1708–1724, 2010.
View at: Publisher Site | Google Scholar
R. C. Page, S. Offenbacher, H. E. Schroeder, G. J. Seymour, and K. S. Kornman, “Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions,” Periodontology 2000, vol. 14, no. 1, pp. 216–248, 1997.
View at: Publisher Site | Google Scholar
A. Stabholz, W. A. Soskolne, and L. Shapira, “Genetic and environmental risk factors for chronic periodontitis and aggressive periodontitis,” Periodontology 2000, vol. 53, no. 1, pp. 138–153, 2010.
View at: Publisher Site | Google Scholar
F. D'Aiuto, M. Parkar, P. M. Brett, D. Ready, and M. S. Tonetti, “Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections,” Cytokine, vol. 28, no. 1, pp. 29–34, 2004.
View at: Publisher Site | Google Scholar
M. Ianni, G. Bruzzesi, D. Pugliese et al., “Variations in inflammatory genes are associated with periodontitis,” Immunity and Ageing, vol. 10, no. 1, article no. 39, 2013.
View at: Publisher Site | Google Scholar
G. R. Manikandan and P. Janam, “Association of cytokine gene polymorphosis with periodontal disease,” Indian Journal of Human Genetics, vol. 20, article S43, 2014.
View at: Google Scholar
T. C. Hart, D. Pallos, L. Bozzo et al., “Evidence of genetic heterogeneity for hereditary gingival fibromatosis,” Journal of Dental Research, vol. 79, no. 10, pp. 1758–1764, 2000.
View at: Publisher Site | Google Scholar
C. Garbers, S. Aparicio-Siegmund, and S. Rose-John, “The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition,” Current Opinion in Immunology, vol. 34, pp. 75–82, 2015.
View at: Publisher Site | Google Scholar
T. Polepalle, S. Moogala, S. Boggarapu, D. S. Pesala, and F. B. Palagi, “Acute phase proteins and their role in periodontitis: a review,” Journal of Clinical and Diagnostic Research, vol. 9, no. 11, pp. ZE01–ZE05, 2015.
View at: Publisher Site | Google Scholar
L. K. McCauley and R. M. Nohutcu, “Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy,” Journal of Periodontology, vol. 73, no. 11, pp. 1377–1391, 2002.
View at: Publisher Site | Google Scholar
H.-Y. Zhang, L. Feng, H. Wu, and X.-D. Xie, “The association of IL-6 and IL-6R gene polymorphisms with chronic periodontitis in a Chinese population,” Oral Diseases, vol. 20, no. 1, pp. 69–75, 2014.
View at: Publisher Site | Google Scholar
C. F. Terry, V. Loukaci, and F. R. Green, “Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation,” Journal of Biological Chemistry, vol. 275, no. 24, pp. 18138–18144, 2000.
View at: Publisher Site | Google Scholar
H. Ma, G. Sun, W. Wang et al., “Association between interleukin-6 -572 C>G and -174 G>C polymorphisms and hypertension: a meta-analysis of case-control studies,” Medicine, vol. 95, no. 2, Article ID e2416, 2016.
View at: Publisher Site | Google Scholar
P. M. Brett, P. Zygogianni, G. S. Griffiths et al., “Functional gene polymorphisms in aggressive and chronic periodontitis,” Journal of Dental Research, vol. 84, no. 12, pp. 1149–1153, 2005.
View at: Publisher Site | Google Scholar
P. L. Casado, R. Villas-Boas, W. de Mello, M. E. L. Duarte, and J. M. Granjeiro, “Peri-implant disease and chronic periodontitis: is interleukin-6 gene promoter polymorphism the common risk factor in a Brazilian population?” The International Journal of Oral & Maxillofacial Implants, vol. 28, no. 1, pp. 35–43, 2013.
View at: Publisher Site | Google Scholar
A. M. Costa, M. C. M. Guimarães, E. R. De Souza, O. T. Nóbrega, and A. C. B. Bezerra, “Interleukin-6 (G-174C) and tumour necrosis factor-alpha (G-308A) gene polymorphisms in geriatric patients with chronic periodontitis,” Gerodontology, vol. 27, no. 1, pp. 70–75, 2010.
View at: Publisher Site | Google Scholar
V. Dosseva-Panova, A. Mlachkova, C. Popova, and M. Kicheva, “Evaluation of interleukin-6, lymphotoxin-α and TNF-α gene polymorphisms in chronic periodontitis,” Journal of IMAB—Annual Proceeding, vol. 21, pp. 868–875, 2015.
View at: Google Scholar
W. H. Fan, D. L. Liu, L. M. Xiao, C. J. Xie, S. Y. Sun, and J. C. Zhang, “Coronary heart disease and chronic periodontitis: is polymorphism of interleukin-6 gene the common risk factor in a Chinese population?” Oral Diseases, vol. 17, no. 3, pp. 270–276, 2011.
View at: Publisher Site | Google Scholar
Y. Komatsu, H. Tai, J. C. Galicia et al., “Interleukin-6 (IL-6)—373 A9T11 allele is associated with reduced susceptibility to chronic periodontitis in Japanese subjects and decreased serum IL-6 level,” Tissue Antigens, vol. 65, no. 1, pp. 110–114, 2005.
View at: Publisher Site | Google Scholar
G. G. Song, S. J. Choi, J. D. Ji, and Y. H. Lee, “Association between tumor necrosis factor-α promoter -308 A/G, -238 A/G, interleukin-6 -174 G/C and -572 G/C polymorphisms and periodontal disease: a meta-analysis,” Molecular Biology Reports, vol. 40, no. 8, pp. 5191–5203, 2013.
View at: Publisher Site | Google Scholar
F. Gabriela Teixeira, S. A. Mendonça, K. Menezes Oliveira et al., “Interleukin-6 c.-174G > C polymorphism and periodontitis in a Brazilian population,” Molecular Biology International, vol. 2014, Article ID 490308, 8 pages, 2014.
View at: Publisher Site | Google Scholar
L. Scapoli, A. Girardi, A. Palmieri et al., “Interleukin-6 gene polymorphism modulates the risk of periodontal diseases,” Journal of Biological Regulators and Homeostatic Agents, vol. 29, no. 3, supplement 1, pp. 111–116, 2015.
View at: Google Scholar
N. Sharma, R. Joseph, R. Arun, R. Chandni, K. Srinivas, and M. Banerjee, “Cytokine gene polymorphism (interleukin-1β +3954, Interleukin-6 [-597/-174] and tumor necrosis factor-α-308) in chronic periodontitis with and without type 2 diabetes mellitus,” Indian Journal of Dental Research, vol. 25, no. 3, pp. 375–380, 2014.
View at: Publisher Site | Google Scholar
F. A. Stefani, M. B. Viana, A. C. Dupim et al., “Expression, polymorphism and methylation pattern of interleukin-6 in periodontal tissues,” Immunobiology, vol. 218, no. 7, pp. 1012–1017, 2013.
View at: Publisher Site | Google Scholar
Y. Tian, J.-L. Li, L. Hao et al., “Association of cytokines, high sensitive C-reactive protein, VEGF and beta-defensin-1 gene polymorphisms and their protein expressions with chronic periodontitis in the chinese population,” International Journal of Biological Markers, vol. 28, no. 1, pp. 100–107, 2013.
View at: Publisher Site | Google Scholar
S. C. Trindade, T. Olczak, I. S. Gomes-Filho et al., “Porphyromonas gingivalis hmuy-induced production of interleukin-6 and il-6 polymorphism in chronic periodontitis,” Journal of Periodontology, vol. 84, no. 5, pp. 650–655, 2013.
View at: Publisher Site | Google Scholar
L. Shamseer, D. Moher, M. Clarke et al., “Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation,” The British Medical Journal, vol. 349, Article ID g7647, 2015.
View at: Publisher Site | Google Scholar
N. Babel, G. Cherepnev, D. Babel et al., “Analysis of tumor necrosis factor-α, transforming growth factor-β, interleukin-10, IL-6, and interferon-γ gene polymorphisms in patients with chronic periodontitis,” Journal of Periodontology, vol. 77, no. 12, pp. 1978–1983, 2006.
View at: Publisher Site | Google Scholar
L. I. Holla, A. Fassmann, A. Stejskalová, V. Znojil, J. Vanček, and J. Vacha, “Analysis of the interleukin-6 gene promoter polymorphisms in Czech patients with chronic periodontitis,” Journal of Periodontology, vol. 75, no. 1, pp. 30–36, 2004.
View at: Publisher Site | Google Scholar
H. Jansson, V. Lyssenko, Å. Gustavsson et al., “Analysis of the interleukin-1 and interleukin-6 polymorphisms in patients with chronic periodontitis. A Pilot Study,” Swedish Dental Journal, vol. 30, no. 1, pp. 17–23, 2006.
View at: Google Scholar
N. B. Kalburgi, A. Bhatia, S. Bilichodmath, S. R. Patil, S. B. Mangalekar, and K. Bhat, “Interleukin-6 promoter polymorphism (-174 G/C) in Indian patients with chronic periodontitis,” Journal of Oral Science, vol. 52, no. 3, pp. 431–437, 2010.
View at: Publisher Site | Google Scholar
W. T. Y. Loo, C.-B. Fan, L.-J. Bai et al., “Gene polymorphism and protein of human pro- and anti-inflammatory cytokines in Chinese healthy subjects and chronic periodontitis patients,” Journal of Translational Medicine, vol. 10, supplement 1, article no. S8, 2012.
View at: Google Scholar
P. R. Moreira, P. M. A. Lima, K. O. B. Sathler et al., “Interleukin-6 expression and gene polymorphism are associated with severity of periodontal disease in a sample of Brazilian individuals,” Clinical and Experimental Immunology, vol. 148, no. 1, pp. 119–126, 2007.
View at: Publisher Site | Google Scholar
L. Scapoli, A. Girardi, A. Palmieri et al., “IL6 and IL10 are genetic susceptibility factors of periodontal disease,” Dental Research Journal, vol. 9, supplement 2, pp. S197–S201, 2012.
View at: Publisher Site | Google Scholar
T. Tervonen, T. Raunio, M. Knuuttila, and R. Karttunen, “Polymorphisms in the CD14 and IL-6 genes associated with periodontal disease,” Journal of Clinical Periodontology, vol. 34, no. 5, pp. 377–383, 2007.
View at: Publisher Site | Google Scholar
P. C. Trevilatto, R. M. Scarel-Caminaga, R. B. de Brito Jr., A. P. de Souza, and S. R. Line, “Polymorphism at position—174 of IL-6 gene is associated with susceptibility to chronic periodontitis in a Caucasian Brazilian population,” Journal of Clinical Periodontology, vol. 30, no. 5, pp. 438–442, 2003.
View at: Publisher Site | Google Scholar
P. C. Trevilatto, R. B. Brito, R. M. Scarel-Caminaga, A. P. Souza, and S. R. P. Line, “Polymorphism in the promoter of interleukin-6 gene (-174) is associated with chronic periodontal disease,” Journal of Dental Research, vol. 82, p. 259, 2003.
View at: Google Scholar
L. M. Xiao, Y. X. Yan, C. J. Xie et al., “Association among interleukin-6 gene polymorphism, diabetes and periodontitis in a Chinese population,” Oral Diseases, vol. 15, no. 8, pp. 547–553, 2009.
View at: Publisher Site | Google Scholar
G. A. Wells, B. Shea, D. O'connell et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2011, http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
H. Bi, Y. Gan, C. Yang, Y. Chen, X. Tong, and Z. Lu, “Breakfast skipping and the risk of type 2 diabetes: a meta-analysis of observational studies,” Public Health Nutrition, vol. 18, no. 16, pp. 3013–3019, 2014.
View at: Publisher Site | Google Scholar
J. Higgins and S. Green, “Section 9.5. 2 identifying and measuring heterogeneity,” in Cochrane Handbook for Systematic Reviews of Interventions Version 5.0. 1, The Cochrane Collaboration, London, UK, 2008.
View at: Google Scholar
S. Matsui and Y. Ogata, “Effects of miR-223 on expression of IL-1beta and IL-6 in human gingival fibroblasts,” Journal of Oral Science, vol. 58, no. 1, pp. 101–108, 2016.
View at: Publisher Site | Google Scholar
L. Nibali, S. Fedele, F. D'Aiuto, and N. Donos, “Interleukin-6 in oral diseases: a review,” Oral Diseases, vol. 18, no. 3, pp. 236–243, 2012.
View at: Publisher Site | Google Scholar
P. P. Costa, G. L. Trevisan, G. O. Macedo et al., “Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes,” Journal of Periodontology, vol. 81, no. 3, pp. 384–391, 2010.
View at: Publisher Site | Google Scholar
Y. Shimada, Y. Komatsu, I. Ikezawa-Suzuki, H. Tai, N. Sugita, and H. Yoshie, “The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein,” Journal of Periodontology, vol. 81, no. 8, pp. 1118–1123, 2010.
View at: Publisher Site | Google Scholar
G. N. Belibasakis, A. Johansson, Y. Wang et al., “Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin,” Cytokine, vol. 30, no. 2, pp. 56–63, 2005.
View at: Publisher Site | Google Scholar
J. A. Gasche, J. Hoffmann, C. R. Boland, and A. Goel, “Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells,” International Journal of Cancer, vol. 129, no. 5, pp. 1053–1063, 2011.
View at: Publisher Site | Google Scholar
K. Matsushima, E. Ohbayashi, H. Takeuchi, S. Hosoya, Y. Abiko, and M. Yamazaki, “Stimulation of interleukin-6 production in human dental pulp cells by peptidoglycans from lactobacillus casei,” Journal of Endodontics, vol. 24, no. 4, pp. 252–255, 1998.
View at: Publisher Site | Google Scholar
L. Nibali, I. Madden, F. Franch Chillida, L. J. A. Heitz-Mayfield, P. M. Brett, and N. Donos, “IL6 -174 genotype associated with Aggregatibacter actinomycetemcomitans in Indians,” Oral Diseases, vol. 17, no. 2, pp. 232–237, 2011.
View at: Publisher Site | Google Scholar
T. Raunio, M. Nixdorf, M. Knuuttila, R. Karttunen, O. Vainio, and T. Tervonen, “The extent of periodontal disease and the IL-6-174 genotype as determinants of serum IL-6 level,” Journal of Clinical Periodontology, vol. 34, no. 12, pp. 1025–1030, 2007.
View at: Publisher Site | Google Scholar
X.-M. Wei, Y.-J. Chen, L. Wu, L.-J. Cui, D.-W. Hu, and X.-T. Zeng, “Tumor necrosis factor-α G-308A (rs1800629) polymorphism and aggressive periodontitis susceptibility: a meta-analysis of 16 case-control studies,” Scientific Reports, vol. 6, Article ID 19099, 2016.
View at: Publisher Site | Google Scholar
J.-W. Gao, A.-Q. Zhang, W. Pan et al., “Association between IL-6-174G/C polymorphism and the risk of sepsis and mortality: a systematic review and meta-analysis,” PLoS ONE, vol. 10, no. 3, Article ID e0118843, 2015.
View at: Publisher Site | Google Scholar
X. F. Jin, D. L. Wang, Y. Zhou, and H. Xiong, “Association between the interleukin-6-174 G/C polymorphism and risk of ischemic stroke: a meta-analysis,” Genetics and Molecular Research, vol. 14, no. 4, pp. 13076–13083, 2015.
View at: Publisher Site | Google Scholar
N. Joshi, S. Kannan, N. Kotian, S. Bhat, M. Kale, and S. Hake, “Interleukin 6 -174G>C polymorphism and cancer risk: meta-analysis reveals a site dependent differential influence in Ancestral North Indians,” Human Immunology, vol. 75, no. 8, pp. 901–908, 2014.
View at: Publisher Site | Google Scholar
X. Mao, Z. Ke, S. Liu et al., “IL-1β +3953C/T, -511T/C and IL-6 -174C/G polymorphisms in association with tuberculosis susceptibility: a meta-analysis,” Gene, vol. 573, no. 1, pp. 75–83, 2015.
View at: Publisher Site | Google Scholar
Y.-W. Yin, J.-C. Li, M. Zhang et al., “Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects,” Gene, vol. 529, no. 1, pp. 94–103, 2013.
View at: Publisher Site | Google Scholar
K.-H. Lin, S.-C. Feng, Y.-C. Shen et al., “Interleukin-6(-174) locus polymorphism and serum IL-6 levels in normal tension glaucoma,” Ophthalmic Genetics, vol. 35, no. 4, pp. 255–257, 2014.
View at: Publisher Site | Google Scholar
M. C. Oana, B. Claudia, D. Carmen, P. A. Maria, V. Septimiu, and M. Claudiu, “The role of IL-6 572 C/G, 190 C/T, and 174 G/C gene polymorphisms in children’s obesity,” European Journal of Pediatrics, vol. 173, no. 10, pp. 1285–1296, 2014.
View at: Publisher Site | Google Scholar
M. Yang, C. Li, and M. Li, “Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: a meta-analysis,” Biomedical Reports, vol. 2, pp. 637–643, 2014.
View at: Google Scholar
Y. H. Lee, S. J. Choi, and J. D. Ji, “Association between IL-6 -174 G/C, IL-6 -634 G/C, and IFN-γ +874 A/T polymorphisms and susceptibility to recurrent pregnancy loss: a meta-analysis,” Journal of Assisted Reproduction and Genetics, vol. 32, no. 9, pp. 1421–1427, 2015.
View at: Publisher Site | Google Scholar
L. Nibali, F. D'Aiuto, N. Donos et al., “Association between periodontitis and common variants in the promoter of the interleukin-6 gene,” Cytokine, vol. 45, no. 1, pp. 50–54, 2009.
View at: Publisher Site | Google Scholar
Z. H. Liu, Z. H. Wang, Y. M. Xiao, Y. Lu, and Y. P. Lu, “Association between the interleukin-6 gene polymorphisms and renal cancer risk,” Immunology Letters, vol. 164, no. 2, pp. 125–128, 2015.
View at: Publisher Site | Google Scholar
K. Wang, P. S. Dong, H. F. Zhang, Z. J. Li, X. M. Yang, and H. Liu, “Role of interleukin-6 gene polymorphisms in the risk of coronary artery disease,” Genetics and Molecular Research, vol. 14, no. 2, pp. 3177–3183, 2015.
View at: Publisher Site | Google Scholar
M.-Y. Shao, P. Huang, R. Cheng, and T. Hu, “Interleukin-6 polymorphisms modify the risk of periodontitis: a systematic review and meta-analysis,” Journal of Zhejiang University Science B, vol. 10, no. 12, pp. 920–927, 2009.
View at: Publisher Site | Google Scholar
F. Franch-Chillida, L. Nibali, I. Madden, N. Donos, and P. Brett, “Association between interleukin-6 polymorphisms and periodontitis in Indian non-smokers,” Journal of Clinical Periodontology, vol. 37, no. 2, pp. 137–144, 2010.
View at: Publisher Site | Google Scholar
N. Sugita, T. Kobayashi, A. Kikuchi et al., “Immunoregulatory gene polymorphisms in Japanese women with preterm births and periodontitis,” Journal of Reproductive Immunology, vol. 93, no. 2, pp. 94–101, 2012.
View at: Publisher Site | Google Scholar
K. Ishida, T. Kobayashi, S. Ito et al., “Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis,” Journal of Periodontology, vol. 83, no. 7, pp. 917–925, 2012.
View at: Publisher Site | Google Scholar
J. C. Wohlfahrt, T. Wu, J. S. Hodges, J. E. Hinrichs, and B. S. Michalowicz, “No association between selected candidate gene polymorphisms and severe chronic periodontitis,” Journal of Periodontology, vol. 77, no. 3, pp. 426–436, 2006.
View at: Publisher Site | Google Scholar
Y. Komatsu, H. Tai, J. C. Galicia et al., “Interleukin-6 (IL-6) - 373 A9T11 allele is associated with reduced susceptibility to chronic periodontitis in Japanese subjects and decreased serum IL-6 level,” Tissue Antigens, vol. 65, no. 1, pp. 110–114, 2005.
View at: Publisher Site | Google Scholar
P. Borilova Linhartova, J. Vokurka, H. Poskerova, A. Fassmann, and L. Izakovicova Holla, “Haplotype analysis of interleukin-8 gene polymorphisms in chronic and aggressive periodontitis,” Mediators of Inflammation, vol. 2013, Article ID 342351, 8 pages, 2013.
View at: Publisher Site | Google Scholar
G. Prakash, S. Ajay, K. K. Gupta, and B. Mittal, “Role of TNF-A, IL-6 and IL-4 with the susceptibility to chronic periodontitis in North Indian population: a multi-analytic approach,” Molecular Cytogenetics, vol. 7, supplement 1, p. P72, 2014.
View at: Publisher Site | Google Scholar
E. M. Schneider, W. Du, M. Seybold, K. M. Wittkowski, and W. Koenig, “Genetic risk profile in coronary heart disease (CHD) associated with periodontal infections,” Drug Metabolism and Drug Interactions, vol. 27, article A43, 2012.
View at: Google Scholar
A. Baldini, A. Nota, E. Fanti et al., “Genetic polymorphisms of IL-6, IL-10, COX-2, VDR and periodontal disease,” Clinical Chemistry, vol. 58, pp. A38–A39, 2012.
View at: Google Scholar
H. Meiser, D. Schottler, J. Genius, C. Lichy, A. J. Grau, and C. E. Dorfer, “Polymorphism in the promoter of interleukin-6 gene and periodontitis in a south German population,” Journal of Dental Research, vol. 82, p. B362, 2003.
View at: Google Scholar

Copyright

Copyright © 2016 Junfei Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1176

Downloads

908

Citations